LifeWatch™ Receives FDA Clearance for Its Continuous Vital Signs Monitoring Service

Corporate Breaking News

Home : LifeWatch™ Receives FDA Clearance for Its Continuous Vital Signs Monitoring Service

Feb 09 2016	LifeWatch™ Receives FDA Clearance for Its Continuous Vital Signs Monitoring Service
ZUG, Switzerland, February 9, 2016 /PRNewswire/ -- LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services in the digital health market, is pleased to announce that it has received FDA clearance for its...


Source:http://www.prnewswire.com/news-releases/lifewatch-receives-fda-clearance-for-its-continuous-vital-signs-monitoring-service-568128601.html

Related News
» Global Analytics as a Service Market 2016-2020 - Key Vendors are Amazon Web Services, CSC, HP, IBM, Oracle & SAS Institute » Burkfield Continues Tradition of Quality Fireplaces With Trio of New Products